AzTrials
AzTrials

Listening EffortALERTNCT05884879

Listening Effort in Tinnitus Patients

An observational study of Listening Effort and Tinnitus, run by Maastricht University Medical Center at 1 site in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

About 5-15% of the general population experience a chronic ringing, buzzing, hissing or roaring sound in one or two ears, without any external source. This so-called tinnitus can be present in people with normal hearing, but often coexists with hearing loss. Read more about this study

Who is it for?
Ages 18 to 69 yearsHealthy volunteers can take part
Conditions the study is for
Listening Effort, Tinnitus
What is being tested?
Tinnitus simulation
How many people
80 participants
Where
1 siteNetherlands
Study dates
6 Apr 2023to 31 Jul 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 69 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: TINNITUS GROUP: Tinnitus patients visiting the Audiological Centre of Maastricht UMC+, Adelante Zorggroep Hoensbroek and Blerick, Libra Eindhoven, Kentalis Eindhoven, Den Bosch and Nijmegen. CONTROL GROUP: General population visiting the Maastricht UMC+.

Who may be able to join

  • Young adults, i.e. 18-69 year old;
  • Pure tone average <35 dB HL (0.5, 1, 2, 4 kHz);
  • Proficient and native speaker of Dutch language;
  • TINNITUS GROUP: Severe unilateral or bilateral tinnitus disorder (TQ > 46).
  • CONTROL GROUP: No tinnitus.

Who cannot join

  • Significant asymmetric hearing loss: |PTAright - PTAleft| > 15 dB (PTA = pure tone average of 500, 1000, 2000 and 4000 Hz);
  • Significant loss of vision (text on screen at 70 cm should be readable);
  • Frequent user of any of the following devices: Hearing Aid, Bone Conduction Device, Cochlear Implant, Tinnitus Masker;
  • Additional mental or physical disabilities that may prevent active participation and testing as per protocol.

Trial locations and contacts

1 site in 1 country.

Max RW Scheepers, PhD contact

0031620763359

m.scheepers@mumc.nl

Netherlands1 site, 1 recruiting
  • Maastricht UMC+

    Maastricht, Limburg, 6229 HX

    Recruiting

Other trials in Netherlands

About this study

Official title: Assessment of Listening Effort in Tinnitus Patients

About 5-15% of the general population experience a chronic ringing, buzzing, hissing or roaring sound in one or two ears, without any external source. This so-called tinnitus can be present in people with normal hearing, but often coexists with hearing loss. Most people suffering from tinnitus can cope with it, however a minority experiences emotional distress or cognitive dysfunction as a result of the tinnitus, called tinnitus disorder. People suffering from tinnitus disorder regularly complain about an increased experienced effort when listening to speech or other sounds in daily life situations. As this has never been proven scientifically, the investigators aim to evaluate the effect of the tinnitus percept and tinnitus disorder on experienced listening effort by comparing listening effort between a population with tinnitus disorder and a population without tinnitus.

Being tested
Tinnitus simulation
Medical subject headings
Tinnitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tinnitus simulationBehavioural

    The control group will perform speech perception tests and listening effort tests in the absence and presence of a simulated tinnitus percept using a bone vibrator.

Study groups in NCT05884879
Study groupRoleWhat they receive
Tinnitus group* Adults, i.e. 18-69 year old; * Pure tone average <35 dB HL (0.5, 1, 2, 4 kHz); * Proficient and native speaker of Dutch language; * Severe unilateral or bilateral tinnitus disorder (TQ > 46).
Control group* Adults, i.e. 18-69 year old; * Pure tone average <35 dB HL (0.5, 1, 2, 4 kHz); * Proficient and native speaker of Dutch language; * No tinnitus.
Receives: Behavioral: Tinnitus simulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Listening effort

    Subjective listening effort as a function of the speech reception threshold (SRT)

    Measured: 1 day

Secondary outcomes (3)
  1. Listening effort predictability of tinnitus related questionnaire: TQ

    Relative importance of sub scales of tinnitus related questionnaires for predicting the amount of listening effort in tinnitus patients:

    Tinnitus Questionnaire (score 0-84, higher score = more tinnitus disorder)

    Measured: 1 day

  2. Listening effort predictability of tinnitus related questionnaire: TFI

    Relative importance of sub scales of tinnitus related questionnaires for predicting the amount of listening effort in tinnitus patients:

    Tinnitus Functional Index (score 0-100, higher score = more negative impact of tinnitus)

    Measured: 1 day

  3. Listening effort predictability of tinnitus related questionnaire: HADS

    Relative importance of sub scales of tinnitus related questionnaires for predicting the amount of listening effort in tinnitus patients:

    Hospital Anxiety and Depression Scale (score 0-21, higher score = more anxiety and/or depression)

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2023
  2. Study start6 Apr 2023
  3. Primary completion31 Jul 2024 (estimated)
  4. Study completion31 Jul 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05884879
Sponsor's protocol ID
301849
Acronym
ALERT
Status last verified
May 2023
First submitted
28 Apr 2023
Last updated
22 Mar 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Listening Effort and Tinnitus, run by Maastricht University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Max RW Scheepers, PhD (0031620763359, m.scheepers@mumc.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Listening effort (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in